Spacer
Spacer
Login to your account:
Login
Password
  Forgotten password
Spacer
Spacer
USA Map
Spacer
Left top
Spacer 2011 Competition Spacer
Left top
 
Left top
Spacer Signup Spacer
Left top
Spacer
 
Spacer
Spacer
Spacer
Spacer
Spacer
Where am I? > Home > Clinical news headlines
Help Help
Line

US Clinical Researcher Awards Program

Latest Clinical News Headlines

AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloodthinner Brilinta

Sanofi-Aventis has posted a solid set of figures for the second quarter this morning, but has lowered its full-year earnings forecast due to the introduction this week of generic Lovenox in the USA.

Bayer has posted a 1.3% dip in net income for the second quarter to 525 million euros this morning, but the Leverkusen-based firm’s turnover climbed 14.6% to 9.18 billion euros

Allowing American patients to use EU-approved medicines would increase regulatory competition, enable more patient choice and potentially save the lives of those suffering life-threatening illnesses who currently have no treatment options, says a new study.

Legal experts have been reacting to the news that France’s Servier has been accused by the European Commission of providing incorrect information during its recent inquiry into the pharmaceutical sector

Spacer Spacer
Spacer
Sponsors
dashes

I3

dashes

Kendle

dashes

Johnson & Johnson

dashes

AstraZeneca

dashes

GSK

dashes

Johnson & Johnson

dashes

Parexel

dashes



Spacer
Spacer Border
Spacer
Spacer Home | About | Competition categories | Key dates | Enter | Nominate a Colleague | Who leads the competition? | Why should my company get involved? | Attend
Competition outside the Americas
| Who is PharmaTimes?

Contact | FAQ | Terms & Conditions | Privacy Policy | Design by DJM